Cite
Woetmann A, Alhede M, Dabelsteen S, et al. Interleukin-26 (IL-26) is a novel anti-microbial peptide produced by T cells in response to staphylococcal enterotoxin. Oncotarget. 2018;9(28):19481-19489doi: 10.18632/oncotarget.24603.
Woetmann, A., Alhede, M., Dabelsteen, S., Bjarnsholt, T., Rybtke, M., Nastasi, C., Krejsgaard, T., Andersen, M. H., Bonefeld, C. M., Geisler, C., Givskov, M., & Odum, N. (2018). Interleukin-26 (IL-26) is a novel anti-microbial peptide produced by T cells in response to staphylococcal enterotoxin. Oncotarget, 9(28), 19481-19489. https://doi.org/10.18632/oncotarget.24603
Woetmann, Anders, et al. "Interleukin-26 (IL-26) is a novel anti-microbial peptide produced by T cells in response to staphylococcal enterotoxin." Oncotarget vol. 9,28 (2018): 19481-19489. doi: https://doi.org/10.18632/oncotarget.24603
Woetmann A, Alhede M, Dabelsteen S, Bjarnsholt T, Rybtke M, Nastasi C, Krejsgaard T, Andersen MH, Bonefeld CM, Geisler C, Givskov M, Odum N. Interleukin-26 (IL-26) is a novel anti-microbial peptide produced by T cells in response to staphylococcal enterotoxin. Oncotarget. 2018 Apr 13;9(28):19481-19489. doi: 10.18632/oncotarget.24603. eCollection 2018 Apr 13. PMID: 29731960; PMCID: PMC5929403.
Copy
Download .nbib